β-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery

American Journal of Cardiovascular Drugs

Volumn 10, Issue 4, 2010, Pages 247-259

  Angeli, Fabio ^a   Verdecchia, Paolo ^b   Karthikeyan, Ganesan ^c   Mazzotta, Giovanni ^a   Gentile, Giorgio ^d   Reboldi, Gianpaolo ^d  

^a SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^b Hospital of Assisi   (Italy)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Beta adrenergic receptor antagonists, therapeutic use; Cardiovascular disorders, prevention; Mortality, Surgery.

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; ESMOLOL; LABETALOL; METOPROLOL; OXPRENOLOL; PLACEBO; PROPRANOLOL;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EMERGENCY SURGERY; HEART DEATH; HEART RATE; HUMAN; META ANALYSIS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL MORTALITY; SURGICAL RISK; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VASCULAR SURGERY; CARDIOVASCULAR DISEASE; METHODOLOGY; MORTALITY; POSTOPERATIVE COMPLICATION; RISK; SURGERY;

ADRENERGIC BETA-ANTAGONISTS; CARDIOVASCULAR DISEASES; HUMANS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; SURGICAL PROCEDURES, OPERATIVE;

EID: 77954997814     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.2165/11539510-000000000-00000     Document Type: Article

References (64)

1. Fleischmann KE, Beckman JA, Buller CE, et al. 2009 ACCF/AHA focused update on perioperative beta blockade: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2009; 120: 2123-2151
2. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for VascularMedicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116: 1971-1996
3. Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2009; 120: e169-276
4. Poldermans D, Bax JJ, Boersma E, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management inNon-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J 2009; 30: 2769-2812
5. Bangalore S,Wetterslev J, Pranesh S, et al. Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 2008; 372: 1962-1976
6. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 2005; 331: 313-321
7. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 2003; 97: 623-633
8. Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371: 1839-1847
9. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery: Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341: 1789-1794
10. Yang H, Raymer K, Butler R, et al. The effects of perioperative beta-blockade: results of theMetoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006; 152: 983-990
11. Angeli F, Verdecchia P, Del Pinto M, et al. Perioperative beta blockade: the debate continues. Lancet 2009; 373: 627; author reply 628
12. Haynes RB, Wilczynski N, McKibbon KA, et al. Developing optimal search strategies for detecting clinically sound studies in MEDLINE. J Am Med Inform Assoc 1994; 1: 447-458
13. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (Quality of Reporting of Meta-analyses). Lancet 1999; 354: 1896-1900
14. Sutton A, Abrams K, Jones D. Methods for meta-analysis in medical research. Wiley series in probability and statistics. Chichester: JohnWiley & Sons Ltd, 2000
15. Whitehead A. Estimating the treatment difference in an individual trial. In: Meta-analysis of controlled clinical trials. Chichester: John Wiley&Sons Ltd, 2002: 23-50
16. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in metaanalyses. BMJ 2003; 327: 557-560
17. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004; 23: 1351-1375
18. Higgins J,Green S. Cochrane handbook for systematic reviews of interventions version 5.0.0. ed. Oxford: The Cochrane Collaboration, 2008
19. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21: 1559-1573
20. Bayliff CD, Massel DR, Inculet RI, et al. Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery. Ann Thorac Surg 1999; 67: 182-186
21. Brady AR, Gibbs JS, Greenhalgh RM, et al. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 2005; 41: 602-609
22. Cucchiara RF, Benefiel DJ,Matteo RS, et al. Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology 1986; 65: 528-531
23. Davies MJ, Dysart RH, Silbert BS, et al. Prevention of tachycardia with atenolol pretreatment for carotid endarterectomy under cervical plexus blockade. Anaesth Intensive Care 1992; 20: 161-164
24. Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 2009; 249: 921-926
25. Jakobsen CJ, Bille S, Ahlburg P, et al. Perioperative metoprolol reduces the frequency of atrial fibrillation after thoracotomy for lung resection. J Cardiothorac Vasc Anesth 1997; 11: 746-751
26. Jakobsen CJ, Blom L, Brondbjerg M, et al. Effect of metoprolol and diazepam on pre-operative anxiety. Anaesthesia 1990; 45: 40-43
27. Jakobsen CJ, Grabe N, Christensen B. Metoprolol decreases the amount of halothane required to induce hypotension during general anaesthesia. Br J Anaesth 1986; 58: 261-266
28. Juul AB, Wetterslev J, Gluud C, et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 2006; 332: 1482
29. Lai RC, Xu MX, Huang WQ, et al. Beneficial effects of metoprolol on perioperative cardiac function of elderly esophageal cancer patients. Ai Zheng 2006; 25: 609-613
30. MagnussonH, Ponten J, Sonander HG. Methohexitone anaesthesia formicrolaryngoscopy: circulatory modulation with metoprolol and dihydralazine. Br J Anaesth 1986; 58: 976-982
31. Magnusson J, Thulin T, Werner O, et al. Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery. Br J Anaesth 1986; 58: 251-260
32. Miller DR, Martineau RJ. Bolus administration of esmolol for the treatment of intraoperative myocardial ischaemia. Can J Anaesth 1989; 36: 593-597
33. Miller DR, Martineau RJ,Wynands JE, et al. Bolus administration of esmolol for controlling the haemodynamic response to tracheal intubation: the Canadian Multicentre Trial. Can J Anaesth 1991; 38: 849-858
34. Neary WD, McCrirrick A, Foy C, et al. Lessons learned from a randomised controlled study of perioperative beta blockade in high risk patients undergoing emergency surgery. Surgeon 2006; 4: 139-143
35. Raby KE, Brull SJ, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 1999; 88: 477-482
36. Rosenberg J, Overgaard H, Andersen M, et al. Double blind randomised controlled trial of effect of metoprolol on myocardial ischaemia during endoscopic cholangiopancreatography. BMJ 1996; 313: 258-261
37. Stone JG, Foex P, Sear JW, et al. Risk of myocardial ischaemia during anaesthesia in treated and untreated hypertensive patients. Br J Anaesth 1988; 61: 675-679
38. Urban MK, Markowitz SM, Gordon MA, et al. Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 2000; 90: 1257-1261
39. Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998; 88: 7-17 (Pubitemid 128721126)
40. Zaugg M, Bestmann L, Wacker J, et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study. A double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 2007; 107: 33-44
41. Zaugg M, Tagliente T, Lucchinetti E, et al. Beneficial effects from betaadrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 1999; 91: 1674-1686
42. Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004; 23: 1663-1682
43. Shah KB, Kleinman BS,Rao TL, et al. Angina and other risk factors in patients with cardiac diseases undergoing noncardiac operations. Anesth Analg 1990; 70: 240-247
44. Ashton CM, Petersen NJ, Wray NP, et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993; 118: 504-510
45. Badner NH, Knill RL, Brown JE, et al. Myocardial infarction after noncardiac surgery. Anesthesiology 1998; 88: 572-578
46. Kumar R, McKinney WP, Raj G, et al. Adverse cardiac events after surgery: assessing risk in a veteran population. J Gen Intern Med 2001; 16: 507-518
47. Mangano DT, BrownerWS, Hollenberg M, et al. Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA 1992; 268: 233-239
48. London MJ, Itani KM, Perrino Jr AC, et al. Perioperative beta-blockade: a survey of physician attitudes in the department of Veterans Affairs. J Cardiothorac Vasc Anesth 2004; 18: 14-24
49. Dunzendorfer S, Wiedermann CJ. Modulation of neutrophil migration and superoxide anion release by metoprolol. J Mol Cell Cardiol 2000; 32: 915-924
50. Senzaki H, Paolocci N, Gluzband YA, et al. Beta-blockade prevents sustained metalloproteinase activation and diastolic stiffening induced by angiotensin II combined with evolving cardiac dysfunction. Circ Res 2000; 86: 807-815
51. Prabhu SD, Chandrasekar B, Murray DR, et al. Beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 2000; 101: 2103-2109
52. Jenkins NP, Keevil BG, Hutchinson IV, et al. Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease. Am J Med 2002; 112: 269-274
53. Yeager MP, Fillinger MP, Hettleman BD, et al. Perioperative beta-blockade and late cardiac outcomes: a complementary hypothesis. J Cardiothorac Vasc Anesth 2005; 19: 237-241
54. Redelmeier D, Scales D, Kopp A. Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study. BMJ 2005; 331: 932
55. ZauggM, Schaub MC, Pasch T, et al. Modulation of beta-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action. Br J Anaesth 2002; 88: 101-123
56. Stewart LA, Clarke MJ, on behalf of the Cochrane working group on meta-analysis using individual patient data. Practical methodology of metaanalyses (overviews) using updated individual patient data. Stat Med 1995; 14: 2057-2079
57. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297: 845-850
58. Detsky AS, Abrams HB, Forbath N, et al. Cardiac assessment for patients undergoing noncardiac surgery: a multifactorial clinical risk index. Arch Intern Med 1986; 146: 2131-2134
59. Detsky AS, Abrams HB, McLaughlin JR, et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986; 4: 211-219
60. Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989; 110: 859-866
61. Younis LT, Miller DD, Chaitman BR. Preoperative strategies to assess cardiac risk before noncardiac surgery. Clin Cardiol 1995; 18: 447-454
62. Altman DG, Vergouwe Y, Royston P, et al. Prognosis and prognostic research: validating a prognostic model. BMJ 2009; 338: b605
63. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-1049
64. Ford MK, Beattie WS, Wijeysundera DN. Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Ann Intern Med 2010; 152: 26-35